Among the CD1 proteins that present lipid antigens to T cells, CD1d is the only one that stimulates a population of T cells with an invariant T-cell receptor known as NKT cells. Sequencing of a 722 nucleotide gap in the dog (Canis lupus familiaris) genome revealed that the canine CD1D gene lacks a sequence homologous to exon 2 of human CD1D, coding for the start codon and signal peptide. Also, the canine CD1D gene contains three different short tandem repeats that disrupt the expected gene structure. Because canine CD1D cDNA lacks sequences homologous to human exon 2 and 3, the functionality of canine CD1d protein may be affected, and this could have consequences for the development and activation of canine NKT cells.
The CD1 family is a group of non-polymorphic glycoproteins that present lipid antigens to T cells (Porcelli & Modlin 1999; Brigl & Brenner 2004; Barral & Brenner 2007) . Like MHC class I proteins, CD1 proteins are heterodimers of b2 microglobulin and a heavy chain consisting of three extracellular a domains, a transmembrane region and a cytoplasmic tail, each encoded by a separate exon, preceded by an exon that encodes the start codon and signal peptide, and sometimes an additional exon that consists of 5′ UTR only.
Large variation exists in the number of CD1A, CD1B, and CD1C genes between mammalian species, whereas one or two CD1D genes are present in all mammalian species studied to date (Dascher et al. 1999; Hayes & Knight 2001; Eguchi-Ogawa et al. 2007 ; Looringh van Beeck et al. 2008 Beeck et al. , 2009 . CD1d is crucial for the selection (Bendelac et al. 1995) and activation (Kawano et al. 1997 ) of a subset of T cells known as natural killer T (NKT) cells. The canine CD1 locus is located on chromosome 38 and contains one CD1D gene, eight CD1A genes, one CD1C, one CD1B and one CD1E gene (Fig. 1a) (Looringh van Beeck et al. 2008) . In the canine genome (CanFam 3.1) and in the sequence of BAC clone XX-14K12 AC183576.27, the canine CD1D gene is incomplete due to an internal gap of unknown length. Upstream from this gap we detected a sequence with 62% nt identity to exon 1 of human CD1D and downstream from the gap a sequence with 68% identity to human exon 3 (ENST00000368171; www.ensembl.org) (Fig. 1b) . No canine homolog of the human CD1D exon 2 was found. Putative full-length canine exons were found for CD1D exon 4, 5, 6 and 7, with identities of respectively 76%, 84%, 58% and 56% to the corresponding human exons.
To be able to fill the gap in the genomic DNA sequence between exon 1 and exon 3 of canine CD1D, we performed a two-step digestion on BAC clone XX-14K12 DNA using restriction endonuclease HpaI followed by HindIII and NotI (Fig. S1 ). The two restriction fragments containing the gap were subsequently cloned and sequenced. The complete DNA sequence of the gap was obtained and consists of 722 nt (GenBank GU930707) (Fig. 1c) . No canine homolog of the human CD1D exon 2 was found in this DNA sequence.
Using Tandem Repeat Finder, three different types of tandem repeats were identified in the sequence. Tandem repeats occur more frequently in the canine genome compared to other mammalian genomes as a result of an impaired DNA replication and repair mechanism in dogs (Laidlaw et al. 2007) . The repeat fragment size of the first tandem repeat (TR1) is 20 nt and was found five times. The second tandem repeat (TR2) has a fragment size of 12 nt and was repeated twice. The region containing TR1 and TR2 is characterized by a high guanine content (59%), which may explain why this part had not been sequenced before. The motif TR3 consists of a hexanucleotide repeat of the consensus DNA sequence CCCCGT. This tandem repeat was present 10 times and, based on alignment with human CD1D, is located at the intron-exon boundary of canine CD1D homolog of human CD1D exon 3. To determine the presence and the copy number of the tandem repeats in dog breeds other than the Boxer from which BAC clone XX-142K12 was derived, PCR was performed on genomic DNA of three Beagles, three Labrador Retrievers and a wolf. Using a primer set located outside TR3 (primer set 1, Appendix S1), PCR products were generated and sequenced (Fig. S2 ). We found a (CCCCGT) 6 sequence in wolf genomic DNA (GenBank GU930708). In the PCR products of the three Beagles, we only detected the (CCCCGT) 8 sequence (GenBank GU930709). In one Labrador Retriever we found both (CCCCGT) 8 and (CCCCGT) 10 , whereas in the other two Labrador retrievers only (CCCCGT) 10 was found (GenBank GU930710). These findings indicate that TR3 is a variable number tandem repeat with at least three different alleles. This suggests that TR3 is still an active site with tandem duplication events before and after the divergence of domestic dogs from the gray wolf between 15 000 and 100 000 years ago (Lindblad-Toh et al. 2005) .
Using primer set 5 (Appendix S1), we observed differential transcription of CD1D in cDNA from various Beagle tissues (Fig. 2a) . The highest transcription levels were found in thymus, lymph node, spleen, and PBMC, showing that tissue distribution of transcription of CD1D in dogs is comparable to other species and not hampered by the presence of the tandem repeats. Sequencing of CD1D PCR products generated from Beagle thymus-derived cDNA, generated with primer set 6, located outside the full-length coding sequence of human CD1d, revealed that canine CD1D transcript contained exon 1 and exon 4-7 (Genbank JX139112). Longer PCR products were not obtained using this primer set. Figure 2b shows the structure of the human (NM_001766.3; coding sequence 1008 bp) and canine CD1D cDNA sequences (Genbank JX139112; coding sequence 726 bp). Consistent with the absence of an exon 2 homolog in canine genomic DNA, the canine transcript lacks a sequence similar to human exon 2 encoding the signal sequence of CD1d. However, an alternative start codon in the CD1d reading frame was present in exon 1. No signal peptide could be identified. Exon 3, encoding the a1 domain, was also absent in the cDNA. The deletion of nucleotides flanking a repeat is common, and it is likely that TR3 is responsible for the deletion of the first part of canine CD1D exon 3 and its acceptor splice site, explaining the absence of exon 3 in the cDNA. The introns between exon 4-7 were spliced out as expected, and no additional splice variants were found. Because a homolog of exon 3, encoding the a1 domain, was absent, it is not expected that translation of this transcript will lead to a functional CD1d protein. Even though only Beagle CD1d cDNA was analyzed and we cannot formally rule out that other breeds have normal CD1d transcripts, the Beagle CD1d cDNA is consistent with the Boxer CD1D genomic sequence, and we have confirmed the presence of TR3 in Labrador and wolf. Therefore we expect that other dog breeds show the same aberrant CD1d transcript. Together, our findings suggest that, despite gene transcription, expression of the canine CD1d protein is possibly absent or altered in vivo. Consistent with this, a panel of anti CD1d antibodies, raised against different species, did not stain canine thymocytes (Fig. S3) . Our findings raise the question of how the recently described canine NKT cells (Yasuda et al. 2009 ) can be positively selected and activated in the absence of CD1d protein. One possibility is that one of the many canine CD1A, CD1B, or CD1C genes might encode a restriction element for these cells. 
Supplementary Materials and Methods
In silico sequence analysis (Osoegawa et al. 1998) . Rapid alkaline lysis miniprep method (Qiagen) was used followed, by precipitating BAC clone DNA with ice cold isopropanol. BAC DNA was digested using endonuclease HpaI, succeeded by excision and elution of the band containing the gap in the CD1D gene with subsequent digestion with HindIII and NotI (Stratagene) (Fig. S1 ). The two fragments containing the gap were ligated into pcDNA3.1+ vector (Invitrogen) and sequenced, using a method for GC rich sequences, by BaseClear (Leiden, Netherlands).
Genomic DNA and cDNA sequencing
Blood from three Beagles, three Labrador retrievers and a wolf (Canis lupus) was collected according to the regulations of the Animal Ethics Committee of the University of Utrecht, Netherlands (protocol number 2008.II.11.106). Genomic DNA was isolated from EDTA blood from all seven animals, using the salt extraction method (Miller et al. 1988) . Peripheral blood mononuclear cells (PBMC) were isolated from heparinized Beagle blood by standard Ficoll-Hypaque gradient centrifugation. From one Beagle also skin, intestinal tissue, liver, spleen, lymph node and thymus were collected. RNA was isolated from tissues using the RNeasy kit (Qiagen) followed by cDNA synthesis using the iScript kit (Bio-Rad). All genomic DNA and cDNA was frozen at -20˚C until use. To determine the genomic conservation of the CCCCGT-repeat across dog breeds, we performed a hot-start touch down polymerase chain reaction (PCR) using primer set 1 with genomic DNA as template. PCR was performed with Pfu Turbo polymerase (Stratagene) and 4%
dimethyl sulfoxide under the following conditions: 7 min at 98˚C, followed by 35 cycles of 15 s at 95˚C, 15 s at annealing temperature, 30 s at 72˚C, followed by a final elongation of 5 min at 72˚C. After each of the first 20 cycles, the annealing temperature was decreased with 0.5˚C, starting at 69˚C. PCR products were ligated in a pCR4Blunt-TOPO vector (Invitrogen) and vector DNA was sequenced, using a method for GC rich sequences, by BaseClear (Leiden, Netherlands). The expression of canine CD1D was determined in various tissues using PCR conditions as described above with an annealing step at 65˚C for 60 s with primer set 5. To check the quantity of cDNA in each PCR, we performed β-actin-specific PCR in parallel.
Staining canine thymocytes with CD1d mAbs
Canine thymocytes were stained with biotinylated anti-rat CD1d (IgG2a) antibodies WTH-1, WTH-2, WTH-3, the latter has also been designated as 58 ( a. Negative staining of canine thymocytes was observed with biotinylated anti-rat CD1d antibodies (WTH-1, WTH-2 or WTH-3), anti-human CD1d (CD1d42). Anti-canine CD1a8 (CA13.9H11) was used as a positive control for CD1 expression by thymocytes. All primary antibody incubations were followed by incubation with SA-PE or GAM-PE. As a negative control we omitted the primary antibody, and incubated cells only with secondary antibody. b. Staining of ratCD1d-transfected Raji cells and human PBMC was used as a positive control for respectively WTH-1,-2, -3 and CD1d42 (b).
